TCR2 Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRR and other ETFs, options, and stocks.

About TCRR

TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. 

CEO
Garry E. Menzel
CEOGarry E. Menzel
Employees
137
Employees137
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
137
Employees137

TCRR Key Statistics

Market cap
68.72M
Market cap68.72M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
297.56K
Average volume297.56K
High today
$1.89
High today$1.89
Low today
$1.65
Low today$1.65
Open price
$1.68
Open price$1.68
Volume
241.93K
Volume241.93K
52 Week high
$8.82
52 Week high$8.82
52 Week low
$1.60
52 Week low$1.60

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

TCRR Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.